Govt Job for Research Associate at Indian Institute of Technology

The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”.

The Parliamentary Act has given absolute autonomy to the IITs.

When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).

Applications are invited for one post of Research Associate under the project entitled “Superabsorbent Hemostatic Sponges for Arterial Bleeding and Other Wound Types”

Minimum Qualification : PhD in Materials Science/Biological Science

Desirable Experience/Higher Qualification : Candidate with proven experience of working with biodegradable polymers and having hands on experience with processing and characterization of Superabsorbent Hemostatic sponges for arterial bleeding type projects will be given preference.

Candidates are expected to work in multidisciplinary research area. Proficiency in written and spoken English is mandatory.
Salary Range : 35000/- (Fixed) per month

The position is temporary for a maximum of one year or end of project whichever will be earlier.

Last Date for Application : Those interested must send their application on plain paper with resume, list of three references and copies of professional academic records (mark sheet/Certificate) to vverma@iitk.ac.in with cc to gpbajpai@iitk.ac.in latest by 08-02-2021. Hard copy application will not be entertain.

Related Posts

  • Pharma
  • June 24, 2025
  • 99 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 105 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug